{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:46:22Z","timestamp":1789706782231,"version":"4.0.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.autrev.2011.11.009","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T19:30:48Z","timestamp":1323286248000},"page":"A465-A470","source":"Crossref","is-referenced-by-count":180,"title":["Prolactin and autoimmunity"],"prefix":"10.1016","volume":"11","author":[{"given":"Shahar","family":"Shelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Boaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedi","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.11.009_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.1999.tb07629.x","article-title":"Prolactin and neuroimmunomodulation: in vitro and in vivo observations","volume":"876","author":"Chikanza","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2011.11.009_bb0010","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2011.11.009_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4321\/S1137-66272011000200002","article-title":"Biochemical diagnosis of monomeric hyperprolactinemia","volume":"34","author":"Rivero","year":"2011","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.autrev.2011.11.009_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2005.05.014","article-title":"Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes","volume":"101","author":"Peeva","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2011.11.009_bb0025","first-page":"47","article-title":"Macroprolactinaemia","volume":"29","author":"Kostrzak","year":"2010","journal-title":"Pol Merkur Lekarski"},{"key":"10.1016\/j.autrev.2011.11.009_bb0030","first-page":"1763","article-title":"Evaluation and treatment of galactorrhea","volume":"63","author":"Pena","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.autrev.2011.11.009_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM197801262980408","volume":"298","author":"Prolactin","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.11.009_bb0040","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1002\/art.20751","article-title":"First reported pediatric case of systemic lupus erythematosus associated with prolactinoma","volume":"50","author":"Reuman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.009_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10689-007-9178-0","article-title":"Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk","volume":"7","author":"Hietala","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1016\/j.autrev.2011.11.009_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/EJE-11-0076","article-title":"Cancer risk in hyperprolactinemia patients: a population-based cohort study","volume":"165","author":"Berinder","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/JOE-10-0076","article-title":"The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis?","volume":"208","author":"Reuwer","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1567-5769(01)00045-5","article-title":"Estrogen, prolactin, and autoimmunity: actions and interactions","volume":"1","author":"McMurray","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1568-9972(02)00081-2","article-title":"Prolactin and autoimmunity","volume":"1","author":"Vera-Lastra","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.009_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/er.19.3.225","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.autrev.2011.11.009_bb0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1155\/1998\/93086","article-title":"Role of prolactin in the recovered T-cell development of early partially decapitated chicken embryo","volume":"5","author":"Moreno","year":"1998","journal-title":"Dev Immunol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1385\/ENDO:9:2:163","article-title":"Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression","volume":"9","author":"Krumenacker","year":"1998","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2011.11.009_bb0085","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1191\/096120301717164912","article-title":"Prolactin, a lymphocyte growth and survival factor","volume":"10","author":"Buckley","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1677\/joe.0.1780265","article-title":"Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells","volume":"178","author":"Kochendoerfer","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-2478(02)00008-1","article-title":"Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266","volume":"82","author":"Gado","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2011.11.009_bb0100","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/art.24500","article-title":"Prolactin alters the mechanisms of B cell tolerance induction","volume":"60","author":"Saha","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.009_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12016-009-8182-6","article-title":"Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models","volume":"40","author":"Saha","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1191\/096120301717164967","article-title":"Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells","volume":"10","author":"Matera","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-5728(93)90282-4","article-title":"Differential effects of prolactin upon activation and differentiation of human B lymphocytes","volume":"47","author":"Lahat","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1191\/096120398678920316","article-title":"Anti-endothelial cell antibodies in the sera of hyperprolactinemic women","volume":"7","author":"Krause","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0049-0172(91)90028-X","article-title":"Prolactin, immunoregulation, and autoimmune diseases","volume":"20","author":"Jara","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.009_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3181\/00379727-205-43683","article-title":"Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells","volume":"205","author":"Cesario","year":"1994","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.autrev.2011.11.009_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0090-1229(86)90243-6","article-title":"T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment","volume":"38","author":"Vidaller","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF01452255","article-title":"Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus","volume":"17","author":"Jara","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.autrev.2007.11.018","article-title":"Prolactin, dendritic cells, and systemic lupus erythematosus","volume":"7","author":"Jara","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.009_bb0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/096120339600500107","article-title":"Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease","volume":"5","author":"Allen","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0155","first-page":"1075","article-title":"Guidelines for the diagnosis and treatment of hyperprolactinemia","volume":"44","author":"Biller","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.autrev.2011.11.009_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.1986.tb03608.x","article-title":"Asymptomatic hyperprolactinaemia and prolactinoma in the general population\u2014mass screening by paired assays of serum prolactin","volume":"25","author":"Miyai","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.autrev.2011.11.009_bb0165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MOU.0b013e32834bdf01","article-title":"Prolactin in men's health and disease","volume":"21","author":"Bolyakov","year":"2011","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2362.2010.02399.x","article-title":"Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach","volume":"41","author":"Mann","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.autrev.2011.11.009_bb0175","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrendo.2011.37","article-title":"Medical treatment of prolactinomas","volume":"7","author":"Colao","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0180","doi-asserted-by":"crossref","first-page":"35A","DOI":"10.1210\/jcem.96.2.zeg35a","article-title":"Patient guide to hyperprolactinemia diagnosis and treatment","volume":"96","author":"Hoffman","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2011.11.009_bb0185","first-page":"575","article-title":"Diagnosis and management of hyperprolactinemia","volume":"169","author":"Serri","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.autrev.2011.11.009_bb0190","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.autrev.2006.10.005","article-title":"Hyperprolactinemia and autoimmune diseases","volume":"6","author":"Orbach","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.009_bb0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.autrev.2009.02.031","article-title":"Immunomodulatory role of prolactin in diabetes development","volume":"9","author":"Cejkova","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.009_bb0200","first-page":"629","article-title":"No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus","volume":"23","author":"Buskila","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.rdc.2004.10.004","article-title":"The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity","volume":"31","author":"Szyper-Kravitz","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2011.11.009_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/kei115","article-title":"Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity","volume":"45","author":"Leanos-Miranda","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.009_bb0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00296-006-0129-0","article-title":"Correlation between serum prolactin levels and lupus activity","volume":"26","author":"Rezaieyazdi","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.11.009_bb0220","article-title":"Prolactin and autoimmunity : hyperprolactinemia correlates with serositis and anemia in SLE Patients","author":"Orbach","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0225","first-page":"2216","article-title":"Elevated bioactive prolactin levels in systemic lupus erythematosus\u2014association with disease activity","volume":"28","author":"Pacilio","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0230","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1191\/096120301701549688","article-title":"Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity","volume":"10","author":"Jacobi","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0235","first-page":"1514","article-title":"Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays","volume":"34","author":"Cardenas-Mondragon","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0240","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1191\/096120301717164994","article-title":"Prolactin in human systemic lupus erythematosus","volume":"10","author":"Jara","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0245","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/1529-0131(200104)44:4<866::AID-ANR143>3.0.CO;2-6","article-title":"Biologic activity and plasma clearance of prolactin\u2013IgG complex in patients with systemic lupus erythematosus","volume":"44","author":"Leanos-Miranda","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.009_bb0250","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1191\/096120398678920280","article-title":"Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia","volume":"7","author":"Leanos","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0255","first-page":"1546","article-title":"Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity","volume":"28","author":"Leanos-Miranda","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0260","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.4049\/jimmunol.147.11.3780","article-title":"Prolactin influences autoimmune disease activity in the female B\/W mouse","volume":"147","author":"McMurray","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0265","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/cimm.1995.1058","article-title":"Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells","volume":"162","author":"Blank","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0270","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1191\/096120301717165010","article-title":"Bromocriptine treatment of systemic lupus erythematosus","volume":"10","author":"Walker","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0275","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12016-009-8185-3","article-title":"Prolactin and autoimmunity","volume":"40","author":"Jara","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0280","first-page":"2084","article-title":"Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus","volume":"22","author":"McMurray","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0285","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1191\/096120398678920334","article-title":"Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study","volume":"7","author":"Alvarez-Nemegyei","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.11.009_bb0290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1423.031","article-title":"Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial","volume":"1110","author":"Jara","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2011.11.009_bb0295","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1196\/annals.1422.024","article-title":"Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy","volume":"1108","author":"Jara","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2011.11.009_bb0300","first-page":"849","article-title":"Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage","volume":"28","author":"Fojtikova","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0950-3579(96)80018-5","article-title":"The neuroendocrine immunology of rheumatoid arthritis","volume":"10","author":"Chikanza","year":"1996","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0310","first-page":"2077","article-title":"High serum prolactin levels in men with rheumatoid arthritis","volume":"25","author":"Mateo","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0315","first-page":"277","article-title":"Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation","volume":"26","author":"Gutierrez","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0320","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/26.6.433","article-title":"Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis","volume":"26","author":"Berczi","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0325","first-page":"1662","article-title":"Prolactin deficiency in rheumatoid arthritis","volume":"18","author":"Nagy","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0330","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1753-4887.2001.tb05511.x","article-title":"Breastfeeding-related onset, flare, and relapse of rheumatoid arthritis","volume":"59","author":"Hampl","year":"2001","journal-title":"Nutr Rev"},{"key":"10.1016\/j.autrev.2011.11.009_bb0335","first-page":"1577","article-title":"Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity","volume":"22","author":"McMurray","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0340","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF02229718","article-title":"High serum level of prolactin in patients with systemic sclerosis","volume":"15","author":"Kucharz","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0345","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/rheumatology\/36.4.426","article-title":"High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis","volume":"36","author":"Straub","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0350","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1196\/annals.1351.023","article-title":"Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity","volume":"1069","author":"Mirone","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2011.11.009_bb0355","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/rheumatology\/40.3.310","article-title":"Assessment of pituitary gonadotropin release to gonadotropin releasing hormone\/thyroid-stimulating hormone stimulation in women with systemic sclerosis","volume":"40","author":"La Montagna","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.009_bb0360","first-page":"2160","article-title":"Altered diurnal rhythm of prolactin in systemic sclerosis","volume":"27","author":"Hilty","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0365","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biopha.2006.02.007","article-title":"Prolactin synthesis by lymphocytes from patients with systemic sclerosis","volume":"60","author":"Czuwara-Ladykowska","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2011.11.009_bb0370","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2826.2010.01972.x","article-title":"Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis","volume":"22","author":"Markianos","year":"2010","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0375","first-page":"91","article-title":"Ferritin and prolactin levels in multiple sclerosis","volume":"13","author":"Da Costa","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2011.11.009_bb0380","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-510X(91)90094-N","article-title":"Hyperprolactinemia in multiple sclerosis","volume":"102","author":"Kira","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2011.11.009_bb0385","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11060-009-0076-1","article-title":"Multiple sclerosis attacks triggered by hyperprolactinemia","volume":"98","author":"Nociti","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0390","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2377-6-19","article-title":"Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis\u2014reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations","volume":"6","author":"Bergh","year":"2006","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0395","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1398.044","article-title":"Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases","volume":"1109","author":"Orbach","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2011.11.009_bb0400","first-page":"1291","article-title":"The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome","volume":"26","author":"Haga","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0405","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/labinvest.3780027","article-title":"Big prolactin 60 kDa is overexpressed in salivary glandular epithelial cells from patients with Sjogren's syndrome","volume":"80","author":"Steinfeld","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2011.11.009_bb0410","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1297-319X(03)00151-9","article-title":"Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation?","volume":"71","author":"El Miedany","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2011.11.009_bb0415","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.tripleo.2003.10.033","article-title":"A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls","volume":"97","author":"Taiym","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.autrev.2011.11.009_bb0420","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-2001-17904","article-title":"Elevated prolactin to cortisol ratio and polyclonal autoimmune activation in Hashimoto's thyroiditis","volume":"33","author":"Legakis","year":"2001","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2011.11.009_bb0425","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1507\/endocrj.44.89","article-title":"Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis","volume":"44","author":"Notsu","year":"1997","journal-title":"Endocr J"},{"key":"10.1016\/j.autrev.2011.11.009_bb0430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI44073","article-title":"Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans","volume":"121","author":"Yamamoto","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.11.009_bb0435","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/eji.200838852","article-title":"Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes","volume":"39","author":"Kanda","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0440","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1210\/en.2006-1639","article-title":"Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes","volume":"148","author":"Kanda","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2011.11.009_bb0445","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017981","article-title":"Prolactin: does it have a role in the pathogenesis of psoriasis?","volume":"197","author":"Giasuddin","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2011.11.009_bb0450","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2010.10.003","article-title":"Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin","volume":"10","author":"Sousa","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.009_bb0455","first-page":"169","article-title":"Normalization of the prolactin values during alfa-interferon therapy: the considerations with a female patient with anti-HCV-positive chronic hepatitis and prolactin-secreting hypophyseal microadenoma","volume":"147","author":"Zennaro","year":"1996","journal-title":"Clin Ter"},{"key":"10.1016\/j.autrev.2011.11.009_bb0460","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/112067210701700322","article-title":"Serum prolactin levels and Behcet disease","volume":"17","author":"Proenca","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0465","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cbf.1227","article-title":"The relationship between serum prolactin levels and disease activity in patients with Behcet's disease","volume":"24","author":"Atasoy","year":"2006","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.autrev.2011.11.009_bb0470","first-page":"209","article-title":"Prolactin levels in Behcet's disease: no correlation with disease manifestations and activity","volume":"152","author":"Houman","year":"2001","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.autrev.2011.11.009_bb0475","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s100670050117","article-title":"Serum prolactin levels in Behcet's syndrome","volume":"18","author":"Keser","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0480","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/hrt.2009.179218","article-title":"Prolactin: a new therapeutic target in peripartum cardiomyopathy","volume":"96","author":"Yamac","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.autrev.2011.11.009_bb0485","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","article-title":"Peripartum cardiomyopathy","volume":"368","author":"Sliwa","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.11.009_bb0490","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ogc.2010.02.003","article-title":"Update on peripartum cardiomyopathy","volume":"37","author":"Cruz","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.autrev.2011.11.009_bb0495","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2011.11.009_bb0500","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tcm.2008.05.002","article-title":"Peripartum cardiomyopathy: recent insights in its pathophysiology","volume":"18","author":"Hilfiker-Kleiner","year":"2008","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.autrev.2011.11.009_bb0505","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","article-title":"Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study","volume":"121","author":"Sliwa","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.11.009_bb0510","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/adc.77.2.155","article-title":"Serum prolactin in coeliac disease: a marker for disease activity","volume":"77","author":"Reifen","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.autrev.2011.11.009_bb0515","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/tropej\/50.1.37","article-title":"Serum prolactin in celiac disease","volume":"50","author":"Kapur","year":"2004","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.autrev.2011.11.009_bb0520","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/112067210801800612","article-title":"Serum prolactin levels in HLA-B27-associated uveitis","volume":"18","author":"Proenca","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0525","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00166308","article-title":"Elevated prolactin levels in human aqueous humor of patients with anterior uveitis","volume":"229","author":"Pleyer","year":"1991","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.009_bb0530","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1172\/JCI112921","article-title":"Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat","volume":"79","author":"Palestine","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.11.009_bb0535","first-page":"131","article-title":"Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine","volume":"20","author":"Palestine","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.autrev.2011.11.009_bb0540","first-page":"161","article-title":"Bromocriptine in therapy of chronic recurrent anterior uveitis","volume":"88","author":"Zierhut","year":"1991","journal-title":"Fortschr Ophthalmol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T15:03:47Z","timestamp":1686495827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211002837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":108,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1568997211002837"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.11.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}